$BSGM BioSig Technologies (BSGM - $5.48) Laidlaw Report Maintains Buy rating, increase price target from $7 to $10.50. Our price target is based on sum-of-the-parts analysis with $9/share for PURE EP in US, $1/share for PURE EP in EU and $0.50/share for cash and technology.